PAREXEL International Corporation

BOSTON, April 30, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2013, which ended on March 31, 2013. For the three months ended March 31, 2013 consolidated service revenue ... read more

BOSTON, April 30, 2013 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced that today the Company acquired all of the outstanding equity securities of the HERON Group LTD ("HERON"), a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies ... read more

BOSTON, April 24, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it has been named a recipient of the 2013 "Partnership Pioneers of the Year" award in recognition of its innovative strategic partnership with Pfizer and ICON. Given ... read more

BOSTON, April 2, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2013 on Tuesday, April 30, 2013 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and ... read more

BOSTON, March 14, 2013 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) today provided an update and announced the next steps with regard to the Company's share repurchase program. As originally announced on August 8, 2012, the Company's Board of Directors authorized the repurchase of up to $200 ... read more

BOSTON, Feb. 28, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Raymond James Investors Conference in Orlando, FL. James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments ... read more

BOSTON, Feb. 20, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Citi Global Healthcare Conference in New York. James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business ... read more

BOSTON, Jan. 29, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the second quarter of Fiscal Year 2013, which ended on December 31, 2012. For the three months ended December 31, 2012 consolidated service ... read more

BOSTON, Jan. 22, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has selected Xavier Flinois to succeed Steve Kent as president of Perceptive Informatics, PAREXEL's technology division. Steve Kent, who decided to leave the company for personal ... read more

BOSTON, Jan. 10, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Chairman and CEO, Josef von Rickenbach, has been named 2013 chairman of the Association of Clinical Research Organizations (ACRO). Since ... read more

BOSTON, Jan. 4, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the J.P. Morgan Healthcare Conference in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments ... read more

BOSTON, Jan. 3, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Second Quarter of Fiscal Year 2013 on Tuesday, January 29, 2013 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and ... read more

BOSTON, Dec. 27, 2012 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that on December 21, 2012, the Company acquired all of the outstanding equity securities of Liquent, Inc., a leading global provider of Regulatory Information Management (RIM) solutions. Liquent provides an integrated platform of ... read more

BOSTON, Dec. 5, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Oppenheimer Healthcare Conference in New York. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL at 2:10 p.m. EST ... read more

BOSTON and TAIPEI CITY, Taiwan, Nov. 27, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) a leading global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) announced today that they have established an alliance. Under the agreement, PAREXEL and NTUH will collaborate to provide drug ... read more